Page 800 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

References 7

200. Veber B, Souweine B, Gachot B, et al. Comparison of direct 217. Montravers P, Fagon JY, Chastre J, et al. Follow-up protected
examination of three types of bronchoscopy specimens used specimen brushes to assess treatment in nosocomial pneumo-
to diagnose nosocomial pneumonia. Crit Care Med. 2000;28: nia. Am Rev Respir Dis. 1993;147:38-44.
962-968. 218. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J,
201. Timsit JF, Cheval C, Gachot B, et al. Usefulness of a strategy Bohuon C. High serum procalcitonin concentrations in patients
based on bronchoscopy with direct examination of bron- with sepsis and infection. Lancet. 1993;341:515-518.
choalveolar lavage fluid in the initial antibiotic therapy of 219. Christ-Crain M, Opal SM. Clinical review: the role of biomark-
suspected ventilator-associated pneumonia. Intensive Care Med. ers in the diagnosis and management of community-acquired
2001;27:640-647. pneumonia. Crit Care. 2010;14:203.
202. O’Horo JC, Thompson D, Safdar N. Is the Gram stain useful 220. Schuetz P, Albrich W, Christ-Crain M, Chastre J, Mueller B.
in the microbiologic diagnosis of VAP? A meta-analysis. Clin Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti
Infect Dis. 2012;55:551-561. Infect Ther. 2010;8:575-587.
203. de Jaeger A, Litalien C, Lacroix J, Guertin MC, Infante-Rivard 221. Cairns S, Thomas JG, Hooper SJ, et al. Molecular analysis of
C. Protected specimen brush or bronchoalveolar lavage to diag- microbial communities in endotracheal tube biofilms. PLoS
nose bacterial nosocomial pneumonia in ventilated adults: a One. 2011;6:e14759.
meta-analysis. Crit Care Med. 1999;27:2548-2560.
222. Briel M, Schuetz P, Mueller B, et al. Procalcitonin-guided antibi-
204. Torres A, El-Ebiary M. Bronchoscopic BAL in the diagnosis of otic use vs a standard approach for acute respiratory tract infec-
ventilator-associated pneumonia. Chest. 2000;117:198S-202S. tions in primary care. Arch Intern Med. 2008;168:2000-2007;
205. Dreyfuss D, Mier L, Le Bourdelles G, et al. Clinical significance discussion 7-8.
of borderline quantitative protected brush specimen culture 223. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of
results. Am Rev Respir Dis. 1993;147:946-951. procalcitonin-guided treatment on antibiotic use and outcome
206. Marquette CH, Herengt F, Mathieu D, Saulnier F, Courcol R, in lower respiratory tract infections: cluster-randomised, single-
Ramon P. Diagnosis of pneumonia in mechanically ventilated blinded intervention trial. Lancet. 2004;363:600-607.
patients. Repeatability of the protected specimen brush. Am Rev 224. Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin-guidance
Respir Dis. 1993;147:211-214. of antibiotic therapy in community-acquired pneumonia—
207. Timsit JF, Misset B, Francoual S, Goldstein FW, Vaury P, Carlet a randomized trial. Am J Respir Crit Care Med. 2006.
J. Is protected specimen brush a reproducible method to diag- 225. Schuetz P, Christ-Crain M, Thomann R, et al. Effect of procalci-
nose ICU-acquired pneumonia? Chest. 1993;104:104-108. tonin-based guidelines vs standard guidelines on antibiotic use
208. Gerbeaux P, Ledoray V, Boussuges A, Molenat F, Jean P, Sainty in lower respiratory tract infections: the ProHOSP randomized
JM. Diagnosis of nosocomial pneumonia in mechanically ven- controlled trial. JAMA. 2009;302:1059-1066.
tilated patients: repeatability of the bronchoalveolar lavage. Am 226. Stolz D, Christ-Crain M, Bingisser R, et al. Antibiotic treat-
J Respir Crit Care Med. 1998;157:76-80. ment of exacerbations of COPD: a randomized, controlled trial
209. McGowan JE. Antimicrobial resistance in hospital organisms and comparing procalcitonin-guidance with standard therapy. Chest.
its relation to antibiotic use. Rev Infect Dis. 1983;5:1033-1048. 2007;131:9-19.
210. Heyland DK, Cook DJ, Marshall J, et al. The clinical utility 227. Cuquemelle E, Soulis F, Villers D, et al. Can procalcitonin help
of invasive diagnostic techniques in the setting of ventilator- identify associated bacterial infection in patients with severe
associated pneumonia. Canadian Critical Care Trials Group. influenza pneumonia? A multicentre study. Intensive Care Med.
Chest. 1999;115:1076-1084. 2011;37:796-800.
211. Croce MA, Fabian TC, Shaw B, et al. Analysis of charges asso- 228. Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE.
ciated with diagnosis of nosocomial pneumonia: can routine Soluble triggering receptor expressed on myeloid cells and the
bronchoscopy be justified? J Trauma. 1994;37:721-727. diagnosis of pneumonia. N Engl J Med. 2004;350:451-458.
212. Liu YC, Huang WK, Huang TS, Kunin CM. Inappropriate use of 229. Luyt CE, Combes A, Reynaud C, et al. Usefulness of procal-
antibiotics and the risk for delayed admission and masked diag- citonin for the diagnosis of ventilator-associated pneumonia.
nosis of infectious diseases: a lesson from Taiwan. Arch Intern Intensive Care Med. 2008;34:1434-1440.
Med. 2001;161:2366-2370. 230. Luyt CE, Combes A, Trouillet JL, Chastre J. Value of the serum
213. Baughman RP. Nonbronchoscopic evaluation of ventilator- procalcitonin level to guide antimicrobial therapy for patients
associated pneumonia. Semin Respir Infect. 2003;18:95-102. with ventilator-associated pneumonia. Semin Respir Crit Care
214. Jorda R, Parras F, Ibanez J, Reina J, Bergada J, Raurich JM. Med. 2011;32:181-187.
Diagnosis of nosocomial pneumonia in mechanically ventilated 231. Luyt CE, Guerin V, Combes A, et al. Procalcitonin kinetics as
patients by the blind protected telescoping catheter [see com- a prognostic marker of ventilator-associated pneumonia. Am J
ments]. Intensive Care Med. 1993;19:377-382. Respir Crit Care Med. 2005;171:48-53.
215. Souweine B, Veber B, Bedos JP, et al. Diagnostic accuracy of 232. Gibot S, Cravoisy A. Soluble form of the triggering receptor
protected specimen brush and bronchoalveolar lavage in noso- expressed on myeloid cells-1 as a marker of microbial infection.
comial pneumonia: impact of previous antimicrobial treatments Clin Med Res. 2004;2:181-187.
[see comments]. Crit Care Med. 1998;26:236-244. 233. Determann RM, Millo JL, Gibot S, et al. Serial changes in
216. Prats E, Dorca J, Pujol M, et al. Effects of antibiotics on soluble triggering receptor expressed on myeloid cells in the
protected specimen brush sampling in ventilator-associated lung during development of ventilator-associated pneumonia.
pneumonia. Eur Respir J. 2002;19:944-951. Intensive Care Med. 2005;31:1495-1500.

Section04-O-ref.indd 7 1/21/2015 11:23:25 AM